Syndax Pharmaceuticals, Inc. (SNDX)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 21.97 |
| Open | 22.10 |
| Bid | 21.73 x 300 |
| Ask | 21.79 x 200 |
| Day's Range | 21.42 - 22.10 |
| 52 Week Range | 11.22 - 25.34 |
| Volume | |
| Avg. Volume | 1,074,190 |
| Market Cap | 1.848B |
| Beta (5Y Monthly) | 1.01 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- GuruFocus.com
Syndax Pharmaceuticals Inc (SNDX) Q1 2024 Earnings Call Transcript Highlights: Strategic ...
Insights into SNDX's robust pipeline progress, financial health, and strategic plans for upcoming drug launches.
- Zacks
Syndax (SNDX) Gets FDA Priority Tag for Leukemia Drug NDA
Syndax Pharmaceuticals (SNDX) groundbreaking menin inhibitor, revumenib, receives FDA priority review for treating relapsed, refractory acute leukemia.
- Simply Wall St.
Here's Why We're Not Too Worried About Syndax Pharmaceuticals' (NASDAQ:SNDX) Cash Burn Situation
We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
© 2024 Yahoo. All rights reserved.